Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder

Psychoneuroendocrinology

Volumn 40, Issue 1, 2014, Pages 277-283

  Sah, Renu ^a,c   Ekhator, Nosakhare N ^a,c   Jefferson Wilson, Lena ^a,c   Horn, Paul S ^b,c   Geracioti, Thomas D ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; Brain; Cerebrospinal fluid (CSF); Depression; Mood; Neuropeptide Y (NPY); Post traumatic stress disorder (PTSD); Resilience

Indexed keywords

NEUROPEPTIDE Y;

ADULT; AFGHANISTAN; ARMY; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICIAN ADMINISTERED PTSD SCALE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMMUNOREACTIVITY; IRAQ; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; PSYCHOLOGICAL RATING SCALE; PSYCHOTRAUMA; SCORING SYSTEM; SYMPTOM; VETERAN; VOLUNTEER;

ANXIETY; BRAIN; CEREBROSPINAL FLUID (CSF); DEPRESSION; MOOD; NEUROPEPTIDE Y (NPY); POST-TRAUMATIC STRESS DISORDER (PTSD); RESILIENCE;

ADULT; AFGHAN CAMPAIGN 2001-; CASE-CONTROL STUDIES; COMBAT DISORDERS; HUMANS; IRAQ WAR, 2003-2011; MALE; NEUROPEPTIDE Y; STRESS DISORDERS, POST-TRAUMATIC; VETERANS; YOUNG ADULT;

EID: 84893355922     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.10.017     Document Type: Article

References (42)

1. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., Bruce A.B., Orth D.N., Geracioti T.D. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 1999, 156:585-588.
2. Baker D.G., Hauger R.L., Bertram T.M., Patel P.M., Barkauskas D.A., Clopton P., Geracioti T.D., O'Connor D.T., Nievergelt C.M. Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe. The Tenth International Catecholamine Symposium 2012.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
4. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., Keane T.M. The development of a Clinician-Administered PTSD Scale. J. Trauma Stress 1995, 8:75-90.
5. Chen X., Henderson K., Beinfeld M.C., Westfall T.C. Alterations in blood pressure of normotensive and hypertensive rats following intrathecal injections of neuropeptide Y. J. Cardiovasc. Pharmacol. 1988, 12:473-478.
6. Domschke K., Dannlowski U., Hohoff C., Ohrmann P., Bauer J., Kugel H., et al. Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur. Neuropsychopharmacol. 2010, 20:301-309.
7. Dotsch J., Adelmann M., Englaro P., Dotsch A., Hanze J., Blum W.F., Kiess W., Rascher W. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J. Neurol. Sci. 1997, 151:185-188.
8. Geracioti T.D., Baker D.G., Ekhator N.N., West S.A., Hill K.K., Bruce A.B., Schmidt D., Rounds-Kugler B., Yehuda R., Keck P.E., Kasckow J.W. CSF norepinephrine concentrations in posttraumatic stress disorder. Am. J. Psychiatry 2001, 158:1227-1230.
9. Geracioti T.D., Baker D.G., Kasckow J.W., Strawn J.R., Jeffrey M.J., Dashevsky B.A., Horn P.S., Ekhator N.N. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder. Psychoneuroendocrinol 2008, 33:416-424.
10. Giesbrecht C.J., Mackay J.P., Silveira H.B., Urban J.H., Colmers W.F. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J. Neurosci. 2010, 30:16970-16982.
11. Gutman A.R., Yang Y.Y., Ressler K.J., Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J. Neurosci. 2008, 28:12682-12690.
12. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
13. Heilig M., Zachrisson O., Thorsell A., Ehnvall A., Mottagui-Tabar S., Sjogren M., Asberg M., Ekman R., Wahlestedt C., Agren H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J. Psychiatr. Res. 2004, 38:113-121.
14. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022.
15. Kask A., Harro J., Von Horsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 2002, 26:259-283.
16. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
17. Lund M., Foy D., Sipprelle C., Strachan A. The Combat Exposure Scale: a systematic assessment of trauma in the Vietnam War. J. Clin. Psychol. 1984, 40:1323-1328.
18. Makino S., Baker R.A., Smith M.A., Gold P.W. Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants. J. Neuroendocrinol. 2000, 12:387-395.
19. Martin J.R., Knuepfer M.M., Beinfeld M.C., Westfall T.C. Mechanism of pressor response to posterior hypothalamic injection of neuropeptide Y. Am. J. Physiol. 1989, 257:H791-H798.
20. Martinez J.M., Garakani A., Yehuda R., Gorman J.M. Proinflammatory and resiliency proteins in the CSF of patients with major depression. Depress. Anxiety 2012, 29:32-38.
21. McGuire J.L., Larke L.E., Sallee F.R., Herman J.P., Sah R. Differential regulation of neuropeptide Y in the amygdala and prefrontal cortex during recovery from chronic variable stress. Front. Behav. Neurosci. 2011, 5:54.
22. Morgan C.A., Rasmusson A., Wang S., Hoyt G., Hauger R.L., Hazlett G. Neuropeptide Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol. Psychiatry 2002, 52:136-142.
23. Morgan C.A, Wang S., Southwick S.M., Rasmusson A., Hazlett G., Hauger R.L., Charney D.S. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol. Psychiatry 2000, 47:902-909.
24. Morgan C.A., Rasmusson A.M., Winters B., Hauger R.L., Morgan J., Hazlett G., Southwick S. Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels. Biol. Psychiatry 2003, 54:1087-1091.
25. Morris M.J., Hastings J.A., Pavia J.M. Central interactions between noradrenaline and neuropeptide Y in the rat: implications for blood pressure control. Clin. Exp. Hypertens. 1997, 19:619-630.
26. Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathe A.A. Neuropeptide Y and corticotropin releasing hormone in CSF mark response to antidepressive treatment with citalopram. Int. J. Neuropsychopharmacol. 2005, 8:403-410.
27. Rasmusson A.M., Schnurr P.P., Zukowska Z., Scioli E., Forman D.E. Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y, and metabolic syndrome. Exp. Biol. Med. 2010, 235:1150-1162.
28. Redrobe J.P., Dumont Y., St-Pierre J.A., Quirion R. Multiple receptors for NPY in the hippocampus: putative roles in seizures and cognition. Brain Res. 1999, 848:153-166.
29. Redrobe J.P., Dumont Y., Herzog H., Quirion R. Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J. Mol. Neurosci. 2004, 22:159-166.
30. Sah R., Ekhator N.N., Strawn J.R., Sallee F.R., Baker D.G., Horn P.S., Geracioti T.D. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol. Psychiatry 2009, 66:705-707.
31. Sah R., Geracioti T.D. Neuropeptide Y and posttraumatic stress disorder. Mol. Psychiatry 2013, 18:646-655.
32. Sajdyk T.J., Johnson P.L., Leitermann R., Fitz S.D., Dietrich A., Morin M., Gehlert D.R., Urban J.H., Shekhar A. Neuropeptide Y in the amygdala induces long term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J. Neurosci. 2008, 28:893-903.
33. Sergeyev V., Fetissov S., Mathe A.A., Jimenez P.A., Bartfai T., Mortas P., Gaudat L., Moreau J.-L., Hokfelt T. Neuropeptide expression in rats exposed to chronic mild stress. Psychopharmacology 2005, 178:115-124.
34. Serova L.I., Tillinger A., Alaluf L.G., Laukova M., Keegan K., Sabban E.L. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience 2013, 236:298-312.
35. Thorsell A., Wiklund L., Sommer W., Ekman R., Heilig M. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul. Pept. 1998, 75-76:247-254.
36. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., et al. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12852-12857.
37. Widerlov E., Lindstrom L.H., Wahlestedt C., Ekman R. Neuropeptide Y and Peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J. Psychiatr. Res. 1988, 22:69-79.
38. Witt S.H., Buchmann A.F., Blomeyer D., Nieratschker V., Treutlein J., Esser G., Schmidt M.H., Bidlingmaier M., Wiedemann K., Rietschel M., Laucht M., Wust S., Zimmermann U.S. An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 2011, 36:1010-1020.
39. Wu G., Feder A., Wegener G., Bailey C., Saxena S., Charney D., Mathé A.A. Central functions of neuropeptide Y in mood and anxiety disorders. Expert. Opin. Ther. Targets 2011, 15:1317-1331.
40. Yehuda R., Brand S., Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol. Psychiatry 2006, 59:660-663.
41. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.
42. Zukowska-Grojec Z. Neuropeptide Y: a novel sympathetic stress hormone and more. Ann. N. Y. Acad. Sci. 1995, 771:219-233.